Doctors Group Sues FDA over  ( Daxas, Daliresp) ,  Roflumilast for COPD
Channel: VHFILM
Date: 05/02/2014

Highlights:
-Physicians for Integrity in Medical Research says in its federal complaint against Food and Drug Administration Commissioner Margaret Hamburg
- best-case scenario showed that roflumilast reduced the number of exacerbations by one episode a year for every five patients treated
- the regulator ignored the "statistically significant increase in incidents of prostate and lung cancer in patients taking roflumilast."
----------
Possible safe Option Vinpocetine

-Published today in the Proceedings of the National Academy of Sciences vinpocetine has great potential for the treatment of COPD and other inflammatory diseases." 
-has no evidence of toxicity or noticeable side effects in human patients

Links: 
http://healthresearchreport.me/2014/02/04/doctors-group-sues-fda-saying-drug-does-more-harm-than-good/
http://healthresearchreport.me/2012/11/20/purple-periwinkles-battle-inflammatory-diseases-copd/